Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Cash Flow Quality Index
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Cash Flow Quality Index of 1.66x as of September 2025. Operating cash flow of CN¥21.03 Million exceeds net income of CN¥12.65 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Yizhong Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Shanghai Yizhong Pharmaceutical Co Ltd.
Annual Cash Flow Quality Index for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year earnings quality comparison for Shanghai Yizhong Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 5.65x | CN¥39.44 Million | CN¥6.98 Million | ▲ +955.3% |
| 2023 | 0.54x | CN¥86.55 Million | CN¥161.55 Million | ▼ -30.9% |
| 2022 | 0.78x | CN¥110.78 Million | CN¥142.85 Million | — |